KSKhalid Sukar

Khalid Sukar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khalid Sukar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Ki67 Biomarker as a Prognostic Marker in Breast Invasive Ductal Carcinoma in Khartoum State in Sudan

    by Qubaa Ahmed Elzubair, Mohamed Alfaki, Musaab Ahmed Ahmed, Khalid Sukar, Sara Mohammed, Sofiyat Zayyad, Salma Elnour, Salma Mohamed, Abdalraheem Babiker, Asaad Babker, et al.

    Introduction: Worldwide, breast cancer is the most prevalent cancer among women to be diagnosed, and it is the primary cause of cancer-related mortality, coming in second only to lung cancer. High levels of Ki67, a nuclear marker of cell proliferation, in breast cancer are linked to worse outcomes. Methods and materials: This retrospective cross-sectional laboratory investigation aimed to examine Ki67 expression as a prognostic predictor in invasive ductal carcinoma (IDC) utilizing manual tissue microarrays (MTMAs) technology. The study was done from June 2018 to July 2019 at the Elrahman Health Centre in Khartoum, Sudan, using thirty-five paraffin block samples collected from patients previously diagnosed with invasive ductal carcinoma (IDC). The study population ranged in age from 31 to 71 years. Results: The study found that 94.3% (n=33/35) of the tissues were positive for the Ki67 antigen, while 5.7% (n=2/35) were negative. Age and score correlation is (P=0.047), and a favorable prognosis could be the cause of the two unfavorable results. Conclusion: This study highlights the importance of the Ki67 biomarker as a prognostic indicator in invasive ductal carcinoma (IDC) of the breast. High levels of Ki67 expression (94.3%) were associated with more aggressive tumors and poorer prognostic outcomes. However, there was no significant correlation between Ki67 scores and patient age, indicating age does not influence the prognostic value of Ki67 in this cohort.

  • Open Access

    Neutrophil-lymphocyte ratio as a biomarker for urinary tract infection in female patients at Thumbay University Hospital, Ajman

    by Bissan Elattar, Rahaf Ka’ki, Samar Alansawi, Marwan Ismail, Hassan Higazi, Salah Hussein, Sara Mohammed Ali Mohammed, Salma Elnour, Nour Farajallah, Khalid Sukar

    Short urethras make urinary tract infections (UTIs) common in women. Therefore, bacteria can enter the bladder more easily. This research aimed to determine if the neutrophil-to-lymphocyte ratio (NLR) can be used as a biomarker in UTI patients and compare C-reactive protein (CRP) and NLR to identify which is more effective in diagnosing UTI patients. This study examined urine culture, NLR, and CRP values in blood from 101 Thumbay University Hospital patients with UTI. Control group NLR and CRP values of 100 participants were also examined. NLR mean for UTI patients was 6.9881. The NLR mean for UTI-free participants was 3.0839. Comparison of NLR values between UTI patients and non-UTI patients showed significant results (P=<0.001). Thus, patients with UTI had significantly higher NLR results than those without UTI, indicating a strong correlation between UTI and higher NLR values. Our results showed that UTI patients had higher NLR and CRP values than healthy controls. In patients with UTI, clinical assessment of symptoms and complaints should be done first, followed by NLR and CRP as inflammatory markers.